Sienna Cancer Diagnostics (ASX:SDX) talks IVD test sales - Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd 00:00:00

Share On Facebook Share On Twitter

Sienna Cancer Diagnostics Limited (ASX:SDX) CEO Matthew Hoskin talks sales from the company's new in vitro diagnostic (IVD) tests, partnerships and strategy.

Recent Videos